1 |
Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF: miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 104;7080-7085, 2007
DOI
ScienceOn
|
2 |
Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF, Di Virgilio M, Reina San-Martin B, Heidkamp G, Schwickert TA, Eisenreich T, Rajewsky K, Nussenzweig MC: MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28;630-638, 2008
DOI
ScienceOn
|
3 |
Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G, Lugar PL, Lagoo AS, Rizzieri DA, Friedman DR, Weinberg JB, Lipsky PE, Dave SS: Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 113;4586-4594, 2009
DOI
ScienceOn
|
4 |
Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Pérez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM, Weaver WM, Kelso A, Jaenisch R, Wilson CB: A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15;763-774, 2001
DOI
ScienceOn
|
5 |
Banerjee A, Schambach F, DeJong CS, Hammond SM, Reiner SL: Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol 40;225-231, 2010
|
6 |
Neilson JR, Zheng GX, Burge CB, Sharp PA: Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 21;578-589, 2007
DOI
ScienceOn
|
7 |
Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S: Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325;1006-1010, 2009
DOI
|
8 |
Tufekci KU, Oner MG, Genc S, Genc K: MicroRNAs and Multiple Sclerosis. Autoimmune Dis 2011;807426, 2010
|
9 |
Navarro F, Lieberman J: Small RNAs guide hematopoietic cell differentiation and function. J Immunol 184;5939- 5947, 2010
DOI
ScienceOn
|
10 |
Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A: MicroRNAs, macrocontrol: regulation of miRNA processing. RNA 16;1087-1095, 2010
DOI
ScienceOn
|
11 |
Chen CZ, Li L, Lodish HF, Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303;83-86, 2004
DOI
ScienceOn
|
12 |
Kim VN, Han J, Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10;126-139, 2009
DOI
ScienceOn
|
13 |
Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136;215-233, 2009
DOI
ScienceOn
|
14 |
Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD: MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9;839-845, 2008
DOI
ScienceOn
|
15 |
Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman- Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C: Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 81;829-834, 2007
DOI
ScienceOn
|
16 |
Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA: A miRNA signature of prion induced neurodegeneration. PLoS One 3;e3652, 2008
DOI
|
17 |
Pandey AK, Agarwal P, Kaur K, Datta M: MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem 23;221-232, 2009
DOI
ScienceOn
|
18 |
Lodish HF, Zhou B, Liu G, Chen CZ: Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8;120-130, 2008
DOI
ScienceOn
|
19 |
Xiao C, Rajewsky K: MicroRNA control in the immune system: basic principles. Cell 136;26-36, 2009
DOI
ScienceOn
|
20 |
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353;1793-1801, 2005
DOI
ScienceOn
|
21 |
Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL: The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 28;14341-14346, 2008
DOI
ScienceOn
|
22 |
Lindsay MA: microRNAs and the immune response. Trends Immunol 29;343-351, 2008
DOI
ScienceOn
|
23 |
Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A: Requirement of bic/microRNA-155 for normal immune function. Science 316;608-611, 2007
DOI
ScienceOn
|
24 |
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299;425-436, 2008
DOI
ScienceOn
|
25 |
Waldman SA, Terzic A: MicroRNA signatures as diagnostic and therapeutic targets. Clin Chem 54;943-944, 2008
DOI
ScienceOn
|
26 |
204. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K: MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113;396-402, 2009
|
27 |
Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E: Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol 182;2578-2582, 2009
DOI
ScienceOn
|
28 |
Divekar AA, Dubey S, Gangalum PR, Singh RR: Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol 186;924-930, 2011
DOI
ScienceOn
|
29 |
Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY: Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445;936-940, 2007
DOI
ScienceOn
|
30 |
Zhou L, Seo KH, Wong HK, Mi QS: MicroRNAs and immune regulatory T cells. Int Immunopharmacol 9;524-527, 2009
DOI
ScienceOn
|
31 |
Redouane R, Hussein FK, Nabil EZ, Philippe L, Francoise R, Alexandru S, Haidar A, Mohamad M, Mohamad ER, Arsene B, Pedro R, Philippe M, Bassam B: Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39; 1-11, 2009
|
32 |
Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX, Zhang GM, Feng ZH: miR-142-3p restricts cAMP production in CD4+CD25− T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 10;180-185, 2009
DOI
ScienceOn
|
33 |
Ha TY, Waksman BH, Treffers HP: The thymic suppressor cell. I. Separation of subpopulations with suppressor activity. J Exp Med 139;13-23, 1974
DOI
ScienceOn
|
34 |
Gershon RK, Kondo K: Infectious immunological tolerance. Immunology 21;903-914, 1971
|
35 |
Gershon RK, Cohen P, Hencin R, Liebhaber SA: Suppressor T cells. J Immunol 108;586-590, 1972
|
36 |
Ha TY, Waksman BH: Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients. J Immunol 110;1290-1299, 1973
|
37 |
Ha TY, Waksman BH, Treffers HP: The thymic suppre-sor cell. II. Metabolic requirements of suppressor activity. Immunol Commun 3;351-359, 1974
DOI
|
38 |
Mudd PA, Teague BN, Farris AD: Regulatory T cells and systemic lupus erythematosus. Scand J Immunol 64;211- 218, 2006
DOI
ScienceOn
|
39 |
Waksman BH: Tolerance, the thymus, and suppressor T cells. Clin Exp Immunol 28;363-374, 1977
|
40 |
Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell 133;775-787, 2008
DOI
ScienceOn
|
41 |
Sakaguchi S: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22;531-562, 2004
DOI
ScienceOn
|
42 |
Ziegler SF: FOXP3: Of Mice and Men. Ann Rev Immunol 24;209-226, 2006
DOI
ScienceOn
|
43 |
Lu LF, Rudensky A: Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev 23;1270-1282, 2009
DOI
ScienceOn
|
44 |
Heneghan HM, Miller N, Kerin MJ: MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 10;543-550, 2010
DOI
ScienceOn
|
45 |
De Smaele E, Ferretti E, Gulino A: MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res 1338;100-111, 2010
DOI
|
46 |
Zhi F, Chen X, Wang S, Xia X, Shi Y, Guan W, Shao N, Qu H, Yang C, Zhang Y, Wang Q, Wang R, Zen K, Zhang CY, Zhang J, Yang Y: The use of hsa-miR-21, hsa-miR- 181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46;1640-1649, 2010
DOI
ScienceOn
|
47 |
Fayyad-Kazan H, Rouas R, Merimi M, El Zein N, Lewalle P, Jebbawi F, Mourtada M, Badran H, Ezzeddine M, Salaun B, Romero P, Burny A, Martiat P, Badran B: Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J Biol Chem 285;20481-20491, 2010
DOI
|
48 |
Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Rothe F, Simion A, Akl H, Mourtada M, El Rifai M, Burny A, Romero P, Martiat P, Badran B: Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39;1608-1618, 2009
DOI
ScienceOn
|
49 |
Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J, Michalek J: microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol 260;70-74, 2010
DOI
ScienceOn
|
50 |
Freier E, Weber CS, Nowottne U, Horn C, Bartels K, Meyer S, Hildebrandt Y, Luetkens T, Cao Y, Pabst C, Muzzulini J, Schnee B, Brunner-Weinzierl MC, Marangolo M, Bokemeyer C, Deter HC, Atanackovic D: Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinology 35;663-673, 2010
DOI
ScienceOn
|
51 |
Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, Yoshimura A, Baltimore D, Rudensky AY: Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142;914-929, 2010
DOI
ScienceOn
|
52 |
Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E: Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204; 1303-1310, 2007
DOI
ScienceOn
|
53 |
Asirvatham AJ, Gregorie CJ, Hu Z, Magner WJ, Tomasi TB: MicroRNA targets in immune genes and the Dicer/ Argonaute and ARE machinery components. Mol Immunol 45;1995-2006, 2008
DOI
ScienceOn
|
54 |
Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137;1005-1017, 2009
DOI
ScienceOn
|
55 |
Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J, Wilson CB, Brockdorff N, Fisher AG, Smale ST, Merkenschlager M: T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 201;1367-1373, 2005
DOI
ScienceOn
|
56 |
Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, Mandelboim M, Mandelboim O: Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9;1065- 1073, 2008
DOI
ScienceOn
|
57 |
Bezman NA, Cedars E, Steiner DF, Blelloch R, Hesslein DG, Lanier LL: Distinct requirements of microRNAs in NK cell activation, survival, and function. J Immunol 185; 3835-3846, 2010
DOI
ScienceOn
|
58 |
Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, Jensen K, Cobb BS, Merkenschlager M, Rajewsky N, Rajewsky K: Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132;860-874, 2008
DOI
ScienceOn
|
59 |
Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K: Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202;261-269, 2005
DOI
ScienceOn
|
60 |
Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G; Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 183;2506-2512, 2009
DOI
ScienceOn
|
61 |
Rossi M, Young JW: Human dendritic cells: potent antigen- presenting cells at the crossroads of innate and adaptive immunity. J Immunol 175;1373-1381, 2005
DOI
|
62 |
Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P: MicroRNA-155 modulates the interleukin- 1 signaling pathway in activated human monocyte- derived dendritic cells. Proc Natl Acad Sci U S A 106;2735-2740, 2009
DOI
ScienceOn
|
63 |
Holmstrøm K, Pedersen AW, Claesson MH, Zocca MB, Jensen SS: Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy. Hum Immunol 71;67-73, 2010
DOI
ScienceOn
|
64 |
Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V, Macino G: An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation- induced cell death in T lymphocytes. Blood 115; 265-273, 2010
DOI
ScienceOn
|
65 |
Curotto de Lafaille MA, Lafaille JJ: Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30;626-635, 2009
DOI
ScienceOn
|
66 |
Wan YY, Flavell RA: 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 220;199-213, 2007
DOI
ScienceOn
|
67 |
Taylor AL, Llewelyn MJ: Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype. J Immunol 185;6591-6598, 2010
DOI
ScienceOn
|
68 |
Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM: Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184;3433-3441, 2010
DOI
ScienceOn
|
69 |
Kerdiles YM, Stone EL, Beisner DL, McGargill MA, Ch'en IL, Stockmann C, Katayama CD, Hedrick SM: Foxo transcription factors control regulatory T cell development and function. Immunity 33;890-904, 2010
DOI
ScienceOn
|
70 |
Procaccini C, De Rosa V, Galgani M, Abanni L, Calì G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, Matarese G: An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33;929- 941, 2010
DOI
ScienceOn
|
71 |
Chougnet CA, Tripathi P, Lages CS, Raynor J, Sholl A, Fink P, Plas DR, Hildeman DA: A major role for Bim in regulatory T cell homeostasis. J Immunol 186;156-163, 2011
DOI
ScienceOn
|
72 |
Schetter AJ, Heegaard NH, Harris CC: Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31;37-49, 2010
DOI
ScienceOn
|
73 |
Stary G, Klein I, Bauer W, Koszik F, Reininger B, Kohlhofer S, Gruber K, Skvara H, Jung T, Stingl G: Glucocorticosteroids modify Langerhans cells to produce and expand regulatory T cells. J Immunol 186; 103-112, 2011
DOI
ScienceOn
|
74 |
Tsitsiou E, Lindsay MA: microRNAs and the immune response. Curr Op Pharmacol 9;514-520, 2009
DOI
ScienceOn
|
75 |
Liston A, Linterman M, Lu LF: MicroRNA in the adaptive Immune system, in sickness and in Health. J Clin Immunol 30;339-346, 2010
DOI
ScienceOn
|
76 |
Witwer KW, Sisk JM, Gama L, Clements JE: MicroRNA regulation of protein expression: rapid and sensitive modulation of the Innate Immune Response. J Immunology 184;2369-2376, 2010
DOI
ScienceOn
|
77 |
Pauley KM, Cha S, Chan EKL: MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32;189-194, 2009
DOI
ScienceOn
|
78 |
Miller BH, Wahlestedt C: MicroRNA dysregulation in psychiatric disease. Brain Res 1338;89-99, 2010
DOI
|
79 |
Pallante P, Visone R, Croce CM, Fusco A: Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17;F91-104, 2010
DOI
ScienceOn
|
80 |
Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills AM, Wirguin I, Rubin LL, Misawa H, Tabin CJ, Brown R Jr, Chen A, Hornstein E: miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107;13111-13116, 2010
DOI
ScienceOn
|
81 |
Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM: Evidence for microRNA involvement in exercise- associated neutrophil gene expression changes. J Appl Physiol 109;252-261, 2010. [Epub 2010 Jan 28]
DOI
|
82 |
Latronico MV, Condorelli G: MicroRNAs and cardiac pathology. Nat Rev Cardiol 6;419-429, 2009
|
83 |
Miranda RC, Pietrzykowski AZ, Tang Y, Sathyan P, Mayfield D, Keshavarzian A, Sampson W, Hereld D: MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 34;575-587, 2010
DOI
ScienceOn
|
84 |
Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116;281-297, 2004
DOI
ScienceOn
|
85 |
Wang QZ, Xu W, Habib N, Xu R: Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 9;572-594, 2009
DOI
ScienceOn
|
86 |
Kato M, Arce L, Natarajan R: MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 4;1255-1266, 2009
DOI
ScienceOn
|
87 |
Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, Print CG, Hull LM: MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 23;265-275, 2009
DOI
|
88 |
Casares N, Rudilla F, Arribillaga L, Llopiz D, Riezu-Boj JI, Lozano T, Lopez-Sagaseta J, Guembe L, Sarobe P, Prieto J, Borras-Cuesta F, Lasarte JJ: A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J Immunol 185;5150-5159, 2010
DOI
ScienceOn
|
89 |
Xiao Y, Li B, Zhou Z, Hancock WW, Zhang H, Greene MI: Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr Opin Immunol 22;583-591, 2010
DOI
ScienceOn
|
90 |
Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75;855-862, 1993
DOI
ScienceOn
|
91 |
O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10;111-122, 2010
DOI
ScienceOn
|
92 |
Winter J, Jung S, Keller S, Gregory RI, Diederichs S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11;228-234, 2009
DOI
ScienceOn
|
93 |
Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75;843-854, 1993
DOI
ScienceOn
|
94 |
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double- stranded RNA in Caenorhabditis elegans. Nature 391;806-811, 1998
DOI
ScienceOn
|
95 |
Esau CC, Monia BP: Therapeutic potential for microRNAs. Adv Drug Deliv Rev 59;101-114, 2007
DOI
ScienceOn
|
96 |
Waldman SA, Terzic A: Applications of microRNA in cancer: Exploring the advantages of miRNA. Clin Transl Sci 2;248-249, 2009
DOI
ScienceOn
|
97 |
Belver L, de Yébenes VG, Ramiro AR: MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33; 713-722, 2010
DOI
ScienceOn
|
98 |
Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13;48-57, 2008
DOI
ScienceOn
|
99 |
Brase JC, Wuttig D, Kuner R, Sültmann H: Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9;306, 2010
DOI
ScienceOn
|
100 |
Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X, Zhang Q, Lonning S, Teicher BA, Lee C: Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor- derived TGF-beta. J Immunol 178;2883-2892, 2007
DOI
|
101 |
Zou W: Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6;295-307, 2006
DOI
ScienceOn
|
102 |
Lizee G, Radvanyi LG, Overwijk WW, Hwu P: Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms. Clin Cancer Res 12;4794- 4803, 2006
DOI
ScienceOn
|
103 |
Riley JL, June CH, Blazar BR: Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30;656-665, 2009
DOI
ScienceOn
|
104 |
Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH: Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes 15;2654-2659, 2001
DOI
ScienceOn
|
105 |
Fazi F, Nervi C: MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res 79;553-561, 2008
DOI
ScienceOn
|
106 |
Trang P, Weidhaas JB, Slack FJ: MicroRNAs as potential cancer therapeutics. Oncogene 27(Suppl 2);S52-57, 2008
DOI
|
107 |
Cai X, Hagedorn CH, Cullen BR: Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10;1957-1966, 2004
DOI
ScienceOn
|
108 |
Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN: The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18;3016-3027, 2004
DOI
ScienceOn
|
109 |
Boyd SD: Everything you wanted to know about small RNA but were afraid to ask. Lab Invest 88;569-578, 2008
DOI
ScienceOn
|
110 |
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155;1151-1164, 1995
|
111 |
Schickel R, Boyerinas B, Park SM, Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27;5959-5974, 2008
DOI
ScienceOn
|
112 |
Bendelac A, Savage PB, Teyton L: The biology of NKT cells. Annu Rev Immunol 25;297-336, 2007
DOI
ScienceOn
|
113 |
Pauley KM, Chan EK: MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci 1143:226-239, 2008
DOI
ScienceOn
|
114 |
Moschos SA, Williams AE, Perry MM, Birrell MA, Belvisi MG, Lindsay MA: Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 8;240, 2007
DOI
|
115 |
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103;2257-2261, 2006
DOI
ScienceOn
|
116 |
Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA: Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445;931-935, 2007
DOI
ScienceOn
|
117 |
Soifer HS, Rossi JJ, Saetrom P: MicroRNAs in disease and potential therapeutic applications. Mol Ther 15;2070-2079, 2007
DOI
ScienceOn
|
118 |
Barringhaus KG, Zamore PD: MicroRNAs: regulating a change of heart. Circulation 119;2217-2224, 2009
DOI
ScienceOn
|
119 |
Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG: microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 107;8231-8236, 2010
DOI
ScienceOn
|
120 |
Slaby O, Svoboda M, Michalek J, Vyzula R: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8;102, 2009
DOI
|
121 |
Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10;704-714, 2009
DOI
ScienceOn
|
122 |
Hooper LV, Macpherson AJ: Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10;159-169, 2010
DOI
ScienceOn
|
123 |
Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179;5082-5089, 2007
DOI
|
124 |
Martino S, di Girolamo I, Orlacchio A, Datti A, Orlacchio A: MicroRNA implications across neurodevelopment and neuropathology. J Biomed Biotechnol 2009;654346, 2009
|
125 |
Luo X, Tsai LM, Shen N, Yu D: Evidence for microRNAmediated regulation in rheumatic diseases. Ann Rheum Dis 69(Suppl 1);i30-36, 2010
DOI
|
126 |
Tili E, Michaille JJ, Costinean S, Croce CM: MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 4;534-541, 2008
|
127 |
Sheedy FJ, O'Neill LA: Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 67(Suppl 3);iii50-55, 2008
DOI
|
128 |
Hubert P, Jacobs N, Caberg JH, Boniver J, Delvenne P: The cross-talk between dendritic and regulatory T cells: good or evil? J Leukoc Biol 82;781-794, 2007
DOI
ScienceOn
|
129 |
Waldman SA, Terzic A: A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer. FEBS J 276;2157-2164, 2009
DOI
ScienceOn
|
130 |
Fulci V, Scappucci G, Sebastiani GD, Giannitti C, Franceschini D, Meloni F, Colombo T, Citarella F, Barnaba V, Minisola G, Galeazzi M, Macino G: miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 71;206-211, 2010
DOI
ScienceOn
|
131 |
Shevach EM: Mechanisms of foxp3+ T regulatory cellmediated suppression. Immunity 30;636-645, 2009
DOI
ScienceOn
|
132 |
Liu X, Zhan Z, Xu L, Ma F, Li D, Guo Z, Li N, Cao X: MiroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol 185;7244-7251, 2010
DOI
ScienceOn
|
133 |
Qin FX: Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host. Cell Mol Immunol 6;3-13, 2009
DOI
ScienceOn
|
134 |
Huehn J, Polansky JK, Hamann A: Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 9;83-89, 2009
DOI
ScienceOn
|
135 |
Ha TY: Regulatory T cell therapy for autoimmune disease. Immune Netw 8;107-123, 2008
DOI
|
136 |
Ha TY: The role of suppressor T cells in bacterial infections. KAST Rev Modern Sci & Technol 4;105-120, 2008
|
137 |
Sakaguchi S, Miyara M, Costantino CM, Hafler DA: FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10;490-500, 2010
DOI
ScienceOn
|
138 |
Ha TY: The role of suppressor T cells in mycobacterial Infection. Korean Lepr Bull 41;3-25, 2008
|
139 |
Ha TY: The role of suppressor T cells in bacterial infections. KAST Rev Modern Sci & Technol 4;105-120, 2008
|
140 |
Beyer M, Schultze JL: Regulatory T cells in cancer. Blood 108;804-811, 2006
DOI
ScienceOn
|
141 |
Curiel TJ: Tregs and rethinking cancer immunotherapy. J Clin Invest 117;1167-1174, 2007
DOI
ScienceOn
|
142 |
Curiel TJ: Regulatory T cells and treatment of cancer. Curr Opin Immunol 20;241-246, 2008
DOI
ScienceOn
|
143 |
Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B: Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3;499-506, 2010
DOI
|
144 |
Fietta AM, Morosini M, Passadore I, Cascina A, Draghi P, Dore R, Rossi S, Pozzi E, Meloni F: Systemic inflammatory response and downmodulation of peripheral CD25+ Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol 70;477-486, 2009
DOI
ScienceOn
|
145 |
Morse MA, Hobeika AC, Osada T, Serra D, Niedzwiecki D, Lyerly HK, Clay TM: Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Blood 112;610-618, 2008
DOI
ScienceOn
|
146 |
Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM: Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61; 6640-6648, 2001
|
147 |
Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM: MicroRNA 29b functions in acute myeloid leukemia. Blood 114;5331-5341, 2009
DOI
ScienceOn
|
148 |
Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451;147-152, 2008
DOI
ScienceOn
|
149 |
Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106;4402-4407, 2009
DOI
ScienceOn
|
150 |
Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K: Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126;1166- 1176, 2010
|
151 |
Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A: Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45;147- 153, 2006
DOI
ScienceOn
|
152 |
Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, Kitagawa Y, Mandelbaum J, Haddad J Jr, Chen CZ, Califano A, Dalla-Favera R: Identification of the human mature B cell miRNome. Immunity 30;744-752, 2009
DOI
ScienceOn
|
153 |
Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102;3627-3632, 2005
DOI
ScienceOn
|
154 |
Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A: BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207;243-249, 2005
DOI
ScienceOn
|
155 |
Turner M, Vigorito E: Regulation of B- and T-cell differentiation by a single microRNA. Biochem Soc Trans 36;531-533, 2008
DOI
ScienceOn
|
156 |
Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM: Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)- miR155 transgenic mice. Proc Natl Acad Sci U S A 103; 7024-7029, 2006
DOI
ScienceOn
|
157 |
Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131;146-159, 2007
DOI
ScienceOn
|
158 |
Li Y, Chan EY, Li J, Ni C, Peng X, Rosenzweig E, Tumpey TM, Katze MG: MicroRNA expression and virulence in pandemic influenza virus-infected mice. J Virol 84;3023-3032, 2010
DOI
ScienceOn
|
159 |
De Santis G, Ferracin M, Biondani A, Caniatti L, Rosaria Tola M, Castellazzi M, Zagatti B, Battistini L, Borsellino G, Fainardi E, Gavioli R, Negrini M, Furlan R, Granieri E: Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 226;165-171, 2010
DOI
ScienceOn
|
160 |
Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K: Regulation of the germinal center response by microRNA-155. Science 316;604-608, 2007
DOI
ScienceOn
|
161 |
Zhang B, Pan X, Cobb GP, Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302;1-12, 2007
DOI
ScienceOn
|
162 |
Yang Y, Ago T, Zhai P, Abdellartif M, Sadoshima J: Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res 108;305-313, 2011
DOI
ScienceOn
|
163 |
Hoefig KP, Heissmeyer V: MicroRNAs grow up in the immune system. Curr Opin Immunol 20:281-287, 2008
DOI
ScienceOn
|
164 |
Lynam-Lennon N, Maher SG, Reynolds JV: The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84;55-71, 2009
DOI
ScienceOn
|
165 |
Hernando E: microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 9;155-160, 2007
DOI
ScienceOn
|
166 |
Osaki M, Takeshita F, Ochiya T: MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13; 658-670, 2008
DOI
ScienceOn
|
167 |
Negrini M, Nicoloso MS, Calin GA: MicroRNAs and cancer-- new paradigms in molecular oncology. Curr Opin Cell Biol 21;470-479, 2009
DOI
ScienceOn
|
168 |
Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller- Ardogan M, Bonauer A, Zeiher AM, Dimmeler S: Circulating microRNAs in patients with coronary artery disease. Circ Res 107;677-684, 2010
DOI
ScienceOn
|
169 |
Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N: Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55;1944-1949, 2009
DOI
ScienceOn
|
170 |
Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, Hofman P: MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem, 16;1047-1061, 2009
DOI
ScienceOn
|
171 |
Lee YS, Dutta A; MicroRNAs in cancer. Annu Rev Pathol 4;199-227, 2009
DOI
ScienceOn
|
172 |
Saito Y, Suzuki H, Hibi T: The role of microRNAs in gastrointestinal cancers. J Gastroenterol 44(Suppl 19):18-22, 2009
DOI
|
173 |
Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 276;5537-5546, 2009
DOI
ScienceOn
|
174 |
Weber MJ: New human and mouse microRNA genes found by homology search. FEBS J 272;59-73, 2005
|
175 |
Zhang B, Farwell MA: microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 12;3-21, 2008
|
176 |
Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6;857-866, 2006
DOI
ScienceOn
|
177 |
Chong MM, Rasmussen JP, Rudensky AY, Littman DR: The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205;2005-2017, 2008
DOI
ScienceOn
|
178 |
Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY: Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205;1993-2004, 2008
DOI
ScienceOn
|
179 |
Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA: Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205;1983-1991, 2008
DOI
ScienceOn
|
180 |
Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M: A role for Dicer in immune regulation. J Exp Med 203;2519-2527, 2006
DOI
ScienceOn
|
181 |
Lu TX, Munitz A, Rothenberg ME: MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182;4994-5002, 2009
DOI
ScienceOn
|
182 |
O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104;1604-1609, 2007
DOI
ScienceOn
|
183 |
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105;10513-10518, 2008
DOI
ScienceOn
|
184 |
Michael A, Barjracharya SD, Yuen PST, Zhou H, Star RA, Illei GG, Alevizos I: Exosome from human saliva as a source of microRNA biomarkers. Oral Dis 16;34-38, 2010
DOI
ScienceOn
|
185 |
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18;997-1006, 2008
DOI
ScienceOn
|
186 |
Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30;899-911, 2009
DOI
ScienceOn
|
187 |
Toda A, Piccirillo CA: Development and function of naturally occurring CD4+CD25+ regulatory T cells. J Leukoc Biol 80;458-470, 2006
DOI
ScienceOn
|
188 |
Wang HY, Wang RF: Regulatory T cells and cancer. Curr Opin Immunol 19;217-223, 2007
DOI
ScienceOn
|
189 |
Han Y, Guo Q, Zhang M, Chen Z, Cao X: CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 182;111-120, 2009
DOI
|
190 |
Maggi E, Cosmi L, Liotta F, Romagnani P, Romagnani S, Annunziato F: Thymic regulatory T cells. Autoimmun Rev 4;579-586, 2005
DOI
ScienceOn
|
191 |
Buckner JH: Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10;849-859, 2010
DOI
ScienceOn
|
192 |
Mabarrack NH, Turner NL, Mayrhofer G: Recent thymic origin, differentiation, and turnover of regulatory T cells. J Leukoc Biol 84;1287-1297, 2008
DOI
ScienceOn
|
193 |
Pedersenrene I, David M: MicroRNAs in the immune response. Cytokine 43;391-394, 2008
DOI
ScienceOn
|
194 |
Bird L: Regulatory T cells: microRNAs maintain identity. Nat Rev Immunol 8;752, 2008
|
195 |
Taganov KD, Boldin MP, Baltimore D: MicroRNAs and immunity: tiny players in a big field. Immunity 26;133-137, 2007
DOI
ScienceOn
|
196 |
Kosaka N, Izumi H, Sekine K, Ochiya T: microRNA as a new immune-regulatory agent in breast milk. Silence 1;7, 2010
DOI
|
197 |
Sonkoly E, Stahle M, Pivarcsi A: MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18;131-140, 2008
DOI
ScienceOn
|
198 |
Fooksman DR, Vardhana S, Vasiliver-Shamis G, Liese J, Blair DA, Waite J, Sacristán C, Victora GD, Zanin-Zhorov A, Dustin ML: Functional anatomy of T cell activation and synapse formation. Annu Rev Immunol 28;79-105, 2010
DOI
ScienceOn
|
199 |
Eller K, Wolf D, Huber JM, Metz M, Mayer G, McKenzie AN, Maurer M, Rosenkranz AR, Wolf AM: IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol 186;83-91, 2011
DOI
ScienceOn
|
200 |
Baeke F, Korf H, Overbergh L, Verstuyf A, Thorrez L, Van Lommel L, Waer M, Schuit F, Gysemans C, Mathieu C: The vitamin D analog, TX527, promotes a human CD4+ CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 186;132-142, 2011
DOI
ScienceOn
|
201 |
Chu CY, Rana TM: Small RNAs: regulators and guardians of the genome. J Cell Physiol 213;412-419 2007
DOI
ScienceOn
|
202 |
Kim VN: Small RNAs: classification, biogenesis, and function. Mol Cells 19;1-15, 2005
DOI
ScienceOn
|
203 |
Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB: Microarray analysis of microRNA expression in peripheral blood cells of systemic erythematosus patients. Lupus 16;936-946, 2007
|
204 |
Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ: miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129;147-161, 2007
DOI
ScienceOn
|
205 |
Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103;12481- 12486, 2006
DOI
ScienceOn
|
206 |
Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X: MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183;2150-2158, 2009
DOI
ScienceOn
|
207 |
Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C: The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31;220-231, 2009
DOI
ScienceOn
|
208 |
Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C, Bozzoni I: A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123;819-831, 2005
DOI
ScienceOn
|
209 |
Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD: Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451;1125-1129, 2008
DOI
ScienceOn
|
210 |
Lapaque N, Walzer T, Méresse S, Vivier E, Trowsdale J: Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 182; 4339-4348, 2009
DOI
ScienceOn
|
211 |
Generali D, Bates G, Berruti A, Brizzi MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S, Dogliotti L, Banham AH, Harris AL, Bottini A, Fox SB: Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients. Clin Cancer Res 15;1046-1051, 2009
DOI
ScienceOn
|
212 |
Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M: microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27;847-859, 2007
DOI
ScienceOn
|
213 |
Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, Loeb GB, Lee H, Yoshimura A, Rajewsky K, Rudensky AY: Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30;80-91, 2009
DOI
ScienceOn
|
214 |
Zhu QY, Liu Q, Chen JX, Lan K, Ge BX: MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 185;7435-7442, 2010
DOI
ScienceOn
|